Section R4-23-702. Hospice Inpatient Facilities

A.      If a pharmacy permittee contracts to provide pharmacy ser- vices to the patients of a hospice inpatient facility as defined in R4-23-110, the pharmacy permittee shall ensure that:

1.        A prescription medication is provided only by a valid pre- scription order for an individual hospice inpatient facility patient, properly labeled for that patient, as specified in this subsection. Nothing in this section shall prevent a provider pharmacy from supplying  non-prescription drugs in a manufacturer’s unopened container;

2.        A prescription medication label for a hospice inpatient facility patient complies with A.R.S. §§ 32-1968 and 36- 2525 and contains:

a.         The drug name, strength, dosage form, and quantity; and

b.        The beyond-use date; and

3.        If the label on the hospice inpatient facility patient’s drug container becomes damaged or soiled, a pharmacist employed by the pharmacy that dispensed the drug con- tainer, through the  exercise of professional judgment, may relabel the drug container. Only a pharmacist is per- mitted to label a drug container or alter the label of a drug container.

B.       A pharmacist may help hospice inpatient facility personnel develop written policies and procedures for the procurement, administration, storage, control, recordkeeping, and disposal of drugs in the facility.

C.      The provider pharmacy may contract with the hospice inpa- tient facility to provide pharmacist services at the facility that include evaluation of the patient’s response to medication ther- apy, identification of potential adverse drug reactions, and rec- ommended appropriate corrective action.

D.      A provider pharmacy that places an emergency drug supply unit at a hospice inpatient facility shall comply with the requirements of R4-23-701.02.

E.       A pharmacy shall not place an automated dispensing system as defined in R4-23-701.04 in a hospice inpatient facility.

F.       Drugs previously dispensed to a patient of the hospice inpa- tient facility by another pharmacy, and drugs previously dis- pensed by the provider pharmacy, shall not be repackaged.

Historical Note

Former Rules 6.8210, 6.8211, 6.8212, 6.8213, 6.8214,

6.8221, 6.8222, 6.8223, 6.8824, 6.8231, 6.8232, 6.8233,

6.8241, 6.8242, and 6.8243; Amended effective August

10, 1978 (Supp. 78-4). Repealed effective December 18, 1992 (Supp. 92-4). New Section made by final rulemak- ing at 19 A.A.R. 2894, effective November 10, 2013

(Supp. 13-3).